These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 7875198)
1. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198 [TBL] [Abstract][Full Text] [Related]
2. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558 [TBL] [Abstract][Full Text] [Related]
3. CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. Poggi A; Pardi R; Pella N; Morelli L; Sivori S; Vitale M; Revello V; Moretta A; Moretta L Eur J Immunol; 1993 Oct; 23(10):2454-63. PubMed ID: 8405045 [TBL] [Abstract][Full Text] [Related]
4. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase. Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145 [TBL] [Abstract][Full Text] [Related]
5. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR. van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709 [TBL] [Abstract][Full Text] [Related]
6. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. Bolhuis RL; Roozemond RC; van de Griend RJ J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649 [TBL] [Abstract][Full Text] [Related]
7. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383 [TBL] [Abstract][Full Text] [Related]
8. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. Aramburu J; Balboa MA; Izquierdo M; López-Botet M J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071 [TBL] [Abstract][Full Text] [Related]
11. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1. van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018 [TBL] [Abstract][Full Text] [Related]
12. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231 [TBL] [Abstract][Full Text] [Related]
13. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. Poggi A; Tomasello E; Revello V; Nanni L; Costa P; Moretta L Int Immunol; 1997 Sep; 9(9):1271-9. PubMed ID: 9310830 [TBL] [Abstract][Full Text] [Related]
14. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
16. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells. Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675 [TBL] [Abstract][Full Text] [Related]
17. Specificity of human T lymphocytes expressing a gamma/delta T cell antigen receptor. Recognition of a polymorphic determinant of HLA class I molecules by a gamma/delta clone. Ciccone E; Viale O; Pende D; Malnati M; Battista Ferrara G; Barocci S; Moretta A; Moretta L Eur J Immunol; 1989 Jul; 19(7):1267-71. PubMed ID: 2527158 [TBL] [Abstract][Full Text] [Related]
18. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing. Perl A; Looney RJ; Ryan DH; Abraham GN J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902 [TBL] [Abstract][Full Text] [Related]
19. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Ciccone E; Pende D; Vitale M; Nanni L; Di Donato C; Bottino C; Morelli L; Viale O; Amoroso A; Moretta A Eur J Immunol; 1994 Apr; 24(4):1003-6. PubMed ID: 8149950 [TBL] [Abstract][Full Text] [Related]
20. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis. Thiele DL; Patel SS; Lipsky PE J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]